Mechanistically, hyperglycemia, accumulation of AGEs, and elevated systemic levels of IL-6 and CRP account for endothelial dysfunction and disruption of tight junction structure, thereby compromising the barrier’s selectivity [84]. The gene discussed is IL6; the disease is Hyperglycemia.